Revision history
EMA recommends authorisation of Rasonque for metastatic pancreatic cancer — 1 version recorded. Nothing here has been overwritten.
-
EMA recommends authorisation of Rasonque for metastatic pancreatic cancer
From the publisher, in order, with its history intact.
EMA recommends authorisation of Rasonque for metastatic pancreatic cancer — 1 version recorded. Nothing here has been overwritten.